Trapido E J
J Natl Cancer Inst. 1981 Nov;67(5):1011-5.
In 1970 a questionnaire was sent to 97,300 married women aged 25-50 years residing in eastern Massachusetts information was requested on use of oral contraceptives (OC), education, and gynecologic and reproductive histories. Subsequent questionnaires were sent in 1973 and 1979 to a subset of the original cohort (37,000) to obtain recent information. Surveillance of 34 hospitals disclosed 622 cases of breast cancer among respondents diagnosed in a 6 1/2-year period. The rate ratio of breast cancer associated with any use of OC was 0.84 (95% confidence limits: 0.7, 1.1). Although certain subgroups users experienced significantly lower rates of hospitalization for breast cancer than did nonusers (including users aged 25-29, those for whom less than or equal to 5 yr had passed since first use, women with ages at birth of first child either before 25 or after 30, and women who first used OC after the birth of the first child), the risk of breast cancer OC after the birth of the first child), the risk of breast cancer was not consistently lower among users of OC. Among nulliparous women, the rate ratio associated with use of OC was 2.1 (0.9, 5.0).
1970年,一份调查问卷被寄给了居住在马萨诸塞州东部的97300名年龄在25至50岁之间的已婚女性,问卷内容涉及口服避孕药(OC)的使用情况、教育程度以及妇科和生育史。1973年和1979年又向最初队列中的一部分人(37000人)发送了后续问卷,以获取最新信息。对34家医院的监测发现,在6年半的时间里,受访者中有622例乳腺癌病例。与任何口服避孕药使用相关的乳腺癌发病率比为0.84(95%置信区间:0.7,1.1)。尽管某些亚组的使用者患乳腺癌的住院率明显低于非使用者(包括年龄在25至29岁的使用者、首次使用后不到或等于5年的使用者、第一个孩子出生时年龄在25岁之前或30岁之后的女性,以及第一个孩子出生后首次使用口服避孕药的女性),但口服避孕药使用者患乳腺癌的风险并非一直较低。在未生育的女性中,与口服避孕药使用相关的发病率比为2.1(0.9,5.0)。